CLDX

Q: What is the price of Celldex Therapeutics (CLDX) today?

The price of Celldex Therapeutics (CLDX) today is US$ 26,47, with a variation of -12.58% compared to the last year. The price of Celldex Therapeutics (CLDX) started the year trading around US$ 25,27 and today it is at US$ 26,47. Follow the real-time price chart, the historical price of Celldex Therapeutics (CLDX), and stock data from Ibovespa and international markets.

Q: When does Celldex Therapeutics (CLDX) pay dividends?

Celldex Therapeutics (CLDX) não distribuiu dividendos no último ano.

Q: Celldex Therapeutics (CLDX) is it worth it?

Currently, Celldex Therapeutics (CLDX) is priced at US$ 26,47, with a P/E of -8,25%, representing a deviation of -14,96% from its historical average P/E. In the last year, the stock showed a variation of -12.58% in its price and distributed US$ 0,00 in dividends, resulting in a Dividend Yield of 0,00%. The total shareholder return was -12,58%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How to buy stocks of Celldex Therapeutics (CLDX)?

Investing in stocks of Celldex Therapeutics (CLDX) can be done in two ways: by buying the stock no exterior. A stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much do 100 stocks of Celldex Therapeutics (CLDX) yield today?

The yield of Celldex Therapeutics (CLDX) was 8,26% in the last month, -12,58% in the last year and 67,96% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of US$ 0,00 in dividends, um Dividend Yield de 0,00%.If you wanted to buy 100 stocks of Celldex Therapeutics (CLDX) today, the total investment would be US$ 2.647,00, based on the current price of US$ 26,47.If past performance were to repeat, the return on your investment would be:In 1 year: US$ 2.314,01In 5 years: US$ 4.445,90In 10 years: 343,85It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Celldex Therapeutics Inc.

Price

US$ 26,47

variation (12m)

-12,58%

p/l

-8,25

p/vp

2,70

DIVIDEND YIELD

0,00%

price CLDX

BVMF

CLDX

If you had invested

years ago

6 months

1 year

5 years

10 years

ago, today you would have

ago, today you would have:

*The figure considers the reinvestment of dividends.

Profitability of CLDX

1 month

3 months

1 year

2 years

5 years

10 years

profitability

1 month

8,26%

3 months

15,19%

1 year

-12,58%

2 years

-1,16%

5 years

67,96%

10 years

-87,01%

real profitability

profitability minus inflation.

1 month

8,26%

3 months

14,77%

1 year

-16,41%

2 years

-9,79%

5 years

24,12%

10 years

-92,22%

Indicators CLDX

check out the fundamentals of Celldex Therapeutics shares

P/E

-8,25

Sector: -3,49 Industry: -3,49

P/SALES RATIO (PSR)

528,99

Sector: -4,23 Industry: -4,23

P/BV

2,70

Sector: 1,90 Industry: 1,90

DIVIDEND YIELD (DY)

0,00%

Sector: - Industry: -

ROA

-30,92%

Sector: -63,54% Industry: -63,54%

ROE

-32,67%

Sector: -70,19% Industry: -70,19%

ROIC

-535,85%

Sector: -2.095,92% Industry: -2.095,92%

NET MARGIN

-100,00%

Sector: -41,67% Industry: -41,67%

GROSS MARGIN

100,00%

Sector: 38,19% Industry: 38,19%

OPERATING MARGIN

-100,00%

Sector: -41,04% Industry: -41,04%

P/EBITDA

-7,27

Sector: -3,69 Industry: -3,69

P/EBIT

-7,17

Sector: -3,68 Industry: -3,68

P/ASSET

2,55

Sector: 1,42 Industry: 1,42

BVPS

9,93

Sector: 1,85 Industry: 1,85

EPS

-3,24

Sector: -2,19 Industry: -2,19

EQUITY / ASSETS

0,95

Sector: 0,42 Industry: 0,42

CAGR REVENUES 5 YEARS

-9,04%

Sector: - Industry: -

CAGR PROFITS 5 YEARS

28,39%

Sector: - Industry: -

CLDX indicators history

DRAG THE FRAME TO SEE MORE DATA

Stocks comparator

DRAG THE FRAME TO SEE MORE DATA

	p/l	p/vp	ROE	dy	market value	net margin
JNJ	17,99	5,85	32,50%	2,66%	US$ 458,87 B	27,75%
PFE	15,32	1,58	10,33%	6,90%	US$ 140,87 B	15,13%
ABBV	108,79	-2.966,40	-2.726,81%	2,79%	US$ 409,36 B	6,45%
NVO	15,47	9,74	62,99%	2,96%	US$ 253,17 B	34,74%
MRK	12,21	4,40	36,03%	3,77%	US$ 215,83 B	28,16%
AZN	28,13	5,85	20,79%	1,85%	US$ 262,04 B	16,23%
BMY	17,14	5,05	29,44%	5,67%	US$ 88,25 B	10,71%
GILD	20,79	7,45	35,82%	2,68%	US$ 145,89 B	24,71%
ZTS	23,71	12,62	53,20%	1,37%	US$ 62,79 B	28,00%
HALO	13,25	23,31	175,93%	0,00%	US$ 7,76 B	48,21%
REGN	13,15	1,98	15,06%	0,47%	US$ 59,29 B	31,83%
AMGN	29,90	21,01	70,29%	3,24%	US$ 156,09 B	14,67%
VRTX	28,91	6,10	21,11%	0,00%	US$ 104,80 B	31,22%
MCK	25,75	-110,60	-429,55%	0,39%	US$ 95,44 B	0,97%
CAH	26,89	-14,13	-52,54%	1,30%	US$ 37,22 B	0,60%
ADMA	16,91	8,80	52,03%	0,00%	US$ 3,50 B	43,51%
BIIB	12,13	1,22	10,08%	0,00%	US$ 21,55 B	17,46%

comparison of CLDX with indexes

If you had invested (change) 2 years years ago, ago, today you would have

R$ 1.000,00 in PETR4 you would have R$ 2.294,60

R$ 1.000,00 in LEVE3 you would have R$ 5.240,60

*The value considers the reinvestment of dividends.

Dividend History CLDX

current DY: 0,00%

5-year average DY: 0,00%

no dividend paid in the period.

ABOUT THE COMPANY Celldex Therapeutics

Celldex Therapeutics Inc.

Average user rating I10

4.0 (0 people)

Estados Unidos

42 years

Foundation: 1983

1990

Year of debut on the stock exchange - 35 years

125

Employees

The Company Celldex Therapeutics Inc. (Estados Unidos), is listed on Nasdaq with a market value of $ 1,77 Billion, having a net worth of $ 655,41 Milhões.

With a total of 125 employees, the company is listed in the sector of Health Care and categorized in industry of Biotechnology.

In the last 12 months the Company had a revenue of $ 3,34 Milhões, which generated a loss in the amount of $ -214,09 Milhões.

As for its main indicators, the Company has a P/E ratio of -8,25, a P/BV ratio of 2,70 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker CLDX.

Market value

US$ 1,77 Billion

Net worth

US$ 655,41 Milhões

US$ 655.410.000,00

Assets

US$ 692,41 Milhões

US$ 692.410.000,00

Total Number of Shares

66,00 Milhões

66.000.000

Average Daily Trading Volume

US$ 1,33 Million

US$ 1.327.792,00

Sector

Health Care

Industry

Biotechnology

CLDX

CLDX revenue and profits

CLDX results

DRAG THE FRAME TO SEE MORE DATA

CLDX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CLDX

Celldex Therapeutics Inc.

Price

variation (12m)

p/l

p/vp

DIVIDEND YIELD

Profitability of CLDX

check out the fundamentals of Celldex Therapeutics shares

P/E

P/SALES RATIO (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

P/EBITDA

P/EBIT

P/ASSET

BVPS

EPS

EQUITY / ASSETS

CAGR REVENUES 5 YEARS

CAGR PROFITS 5 YEARS

If you had invested (change) 2 years years ago, ago, today you would have

current DY: 0,00%

5-year average DY: 0,00%

ABOUT THE COMPANY Celldex Therapeutics

Celldex Therapeutics Inc.

Estados Unidos

42 years

1990

125

PROFIT X PRICE CLDX

CLDX results

CLDX cash flow

evolution of assets - CLDX

CLDX balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

MRK - Merck & Co.

ABBV - AbbVie

PFE - Pfizer

AZN - AstraZeneca

Frequently Asked Questions